216 related articles for article (PubMed ID: 12714522)
21. Involvement of the bcl-6 gene in AIDS-related lymphomas.
Gaidano G; Pastore C; Capello D; Migliazza A; Gloghini A; Saglio G; Carbone A; Dalla-Favera R
Ann Oncol; 1997; 8 Suppl 2():105-8. PubMed ID: 9209652
[TBL] [Abstract][Full Text] [Related]
22. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Deutsch AJ; Aigelsreiter A; Staber PB; Beham A; Linkesch W; Guelly C; Brezinschek RI; Fruhwirth M; Emberger W; Buettner M; Beham-Schmid C; Neumeister P
Blood; 2007 Apr; 109(8):3500-4. PubMed ID: 17197434
[TBL] [Abstract][Full Text] [Related]
23. Aberrant somatic hypermutations in thyroid lymphomas.
Takakuwa T; Miyauchi A; Aozasa K
Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
[TBL] [Abstract][Full Text] [Related]
24. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
25. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma.
Bödör C; Bognár A; Reiniger L; Szepesi A; Tóth E; Kopper L; Matolcsy A
Br J Haematol; 2005 May; 129(3):373-6. PubMed ID: 15842661
[TBL] [Abstract][Full Text] [Related]
26. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6.
Pasqualucci L; Bereshchenko O; Niu H; Klein U; Basso K; Guglielmino R; Cattoretti G; Dalla-Favera R
Leuk Lymphoma; 2003; 44 Suppl 3():S5-12. PubMed ID: 15202519
[TBL] [Abstract][Full Text] [Related]
28. In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection.
Gaidano G; Parsa NZ; Tassi V; Della-Latta P; Chaganti RS; Knowles DM; Dalla-Favera R
Leukemia; 1993 Oct; 7(10):1621-9. PubMed ID: 8412324
[TBL] [Abstract][Full Text] [Related]
29. Nonimmunoglobulin gene hypermutation in germinal center B cells.
Peng HZ; Du MQ; Koulis A; Aiello A; Dogan A; Pan LX; Isaacson PG
Blood; 1999 Apr; 93(7):2167-72. PubMed ID: 10090923
[TBL] [Abstract][Full Text] [Related]
30. Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.
Kreuz S; Holmes KB; Tooze RM; Lefevre PF
Mol Cancer; 2015 Dec; 14():205. PubMed ID: 26643319
[TBL] [Abstract][Full Text] [Related]
31. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
32. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci.
Pasqualucci L; Migliazza A; Fracchiolla N; William C; Neri A; Baldini L; Chaganti RS; Klein U; Küppers R; Rajewsky K; Dalla-Favera R
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11816-21. PubMed ID: 9751748
[TBL] [Abstract][Full Text] [Related]
33. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.
Rossi D; Berra E; Cerri M; Deambrogi C; Barbieri C; Franceschetti S; Lunghi M; Conconi A; Paulli M; Matolcsy A; Pasqualucci L; Capello D; Gaidano G
Haematologica; 2006 Oct; 91(10):1405-9. PubMed ID: 17018394
[TBL] [Abstract][Full Text] [Related]
34. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
Seifert M; Küppers R
Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
[TBL] [Abstract][Full Text] [Related]
35. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
Jardin F; Sahota SS
Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
[TBL] [Abstract][Full Text] [Related]
36. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.
Gagyi E; Balogh Z; Bödör C; Timár B; Reiniger L; Deák L; Csomor J; Csernus B; Szepesi A; Matolcsy A
Haematologica; 2008 Dec; 93(12):1822-8. PubMed ID: 18945749
[TBL] [Abstract][Full Text] [Related]
37. Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes.
Capello D; Fais F; Vivenza D; Migliaretti G; Chiorazzi N; Gaidano G; Ferrarini M
Leukemia; 2000 May; 14(5):811-5. PubMed ID: 10803511
[TBL] [Abstract][Full Text] [Related]
38. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
Carbone A; Gloghini A; Larocca LM; Capello D; Pierconti F; Canzonieri V; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 2001 Feb; 97(3):744-51. PubMed ID: 11157493
[TBL] [Abstract][Full Text] [Related]
39. TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.
Teitell M; Damore MA; Sulur GG; Turner DE; Stern MH; Said JW; Denny CT; Wall R
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9809-14. PubMed ID: 10449776
[TBL] [Abstract][Full Text] [Related]
40. [Study of mutations in 5'-noncoding region of BCL-6 gene in B-cell non-Hodgkin's lymphomas].
Min DL; Zhou XY; Yang WT; Sun MH; Lu HF; Zhang TM; Zheng AH; Cao PZ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):238-41. PubMed ID: 15256116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
